Balyasny Asset Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.14 - $8.31 $85,241 - $115,367	-13,883 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $63,584 - $99,124	13,883 New	13,883 $86,000
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $1.01 Million - $1.77 Million	-339,869 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.67 - $4.97 $907,450 - $1.69 Million	339,869 New	339,869 $1.07 Million
Q3 2018 Nov 14, 2018	SELL	$9.05 - $10.95 $142,990 - $173,010	-15,800 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$10.2 - $13.9 $23,460 - $31,970	2,300 Added 17.04%	15,800 $161,000
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $170,775 - $254,475	13,500 New	13,500 $176,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.